FCT
NVO

Family Capital Trust’s Novo Nordisk NVO Stock Holding History

Family Capital Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-119,830
Closed -$3.2M – 113
2015
Q1 		$3.2M Sell
119,830
-1,674
-1% -$38.5K 1.77% 19
2014
Q4 		$2.57M Buy
121,504
+3,770
+3% +$84.2K 1.34% 28
2014
Q3 		$2.8M Sell
117,734
-200
-0.2% -$4.6K 1.54% 22
2014
Q2 		$2.72M Sell
117,934
-576
-0.5% -$12.7K 1.4% 24
2014
Q1 		$2.71M Hold
118,510
– – 1.47% 24
2013
Q4 		$2.19M Sell
118,510
-1,600
-1% -$27.9K 1.19% 26
2013
Q3 		$2.03M Sell
120,110
-1,190
-1% -$20K 1.22% 31
2013
Q2 		$1.88M Buy
+121,300
New +$2.02M 1.2% 32

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Family Capital Trust's NVO Position: Q2 2015 in Review

Family Capital Trust sold out of Novo Nordisk (NVO) in Q2 2015, closing a stake of 119,830 shares — an estimated $3.2M sold.

Family Capital Trust first reported a position in NVO in Q2 2013 and held it in 8 quarters. The position peaked at $3.2M in Q1 2015. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

  • Family Capital Trust reported no remaining Novo Nordisk position as of Q2 2015 after selling out during the quarter.
  • Family Capital Trust sold 119,830 Novo Nordisk shares in Q2 2015, an estimated $3.2M.
  • Family Capital Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 8 quarters.
  • Family Capital Trust's Novo Nordisk position peaked at $3.2M in Q1 2015.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on Family Capital Trust's 13F filing for Q2 2015, filed 21 Jul 2015.